(Total Views: 560)
Posted On: 02/15/2021 7:24:36 PM
Post# of 153941
Something not talked about at all lately.
Leronlimab for mild/moderate covid-19.
Especially with all the new strands of the virus.
Yes, for m/m there is lots of competition.
But Leronlimab may well stand as the superior one for m/m???
This market is and will remain huger.
Leronlimab for mild/moderate covid-19.
Especially with all the new strands of the virus.
Yes, for m/m there is lots of competition.
But Leronlimab may well stand as the superior one for m/m???
This market is and will remain huger.
(3)
(0)
